Actos and Bladder Cancer

The U.S. Food and Drug Administration (FDA) has issued warning that the use of Actos (pioglitazone), a diabetes medication, for over one (1) year has been associated with a forty-percent (40%) increase in risk for bladder cancer. It has been warned that patients who have been taking Actos to contact a medical doctor if they experience any of the following symptoms:

• blood or red colored urine
• an urgent need to urinate or pain while urinating
• pain in lower abdomen or back.

If you are taking Actos and concerned about the risk of bladder cancer, it is important to speak with your medical provider. It is crucial to speak with a qualified medical provider before changing your treatment regiment or stopping Actos.

The oral diabetes medication, Actos, is made by Takeda Pharmaceutical Company and co-marketed in the United States by Eli Lilly Pharmaceuticals. Actos is used to control type-2 diabetes in those whose condition is not adequately controlled by diet and exercise. Actos belongs to a class of drugs called Thiazolidinedione, which work to lower blood glucose levels and increase the body's sensitivity to insulin. Pioglitazone may be prescribed alone, as Actos, or in combination with other active ingredients such as metformin (sold as Actoplus Met) or glimepiride (sold as Duetact).

The Stewart Law Firm is committed to representing individuals and families in cases involving catastrophic personal injury, wrongful death and defective products. If you have a question about Actos or your legal rights, call The Stewart Law Firm today. You can The Stewart Law Firm, toll-free, at (877) 326-0411. Our address is: 3000 South, IH-35, Suite 150, Austin, TX 78704. Visit The Stewart Law Firm on the web at: www.thestewartlawfirm.net.